Immunotherapy and cancer vaccine biotech
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Ancora | 42 | Holds (flat) | 20,000 | $188,800 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -84% | 37,200 | $351,168 | 0.0% |
| Steve Cohen / Point72 | 75 | Trimmed -22% | 102,700 | $969,488 | 0.0% |
| Filed | Form | Activist | % of class | Conviction | |
|---|---|---|---|---|---|
| 2026-02-25 | SCHEDULE 13D/A | Cambridge Equities, LP | 66.3% | Med | filing |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-09-30 | Lisa McClain MI09 | BUY | $1,001 - $15,000 | PTR |
| 2026-09-28 | Lisa McClain MI09 | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.